Esperion Therapeutics, Inc. Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Esperion Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Esperion Therapeutics, Inc. for June 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 3,846 | 0 | 6,963 | 3.1 K to 7 K (+123.39 %) |
Jun 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 21,471 | 0 | 0 | 21.5 K to 0 (-100.00 %) |
Jun 25 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.57 | 60,000 | 2,314,224 | 3,132,964 | 3.1 M to 3.1 M (+1.95 %) |
Jun 11 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 37.79 | 60,000 | 2,267,292 | 3,072,964 | 3 M to 3.1 M (+1.99 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 17.75 | 8,000 | 142,000 | 0 | |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 14.42 | 5,000 | 72,100 | 0 | |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 8,000 | 0 | 47 | 8 K to 47 (-99.42 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 5,000 | 0 | 8,047 | 13 K to 8 K (-38.32 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | M | 17.75 | 8,000 | 142,000 | 13,047 | 5 K to 13 K (+158.51 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | M | 14.42 | 5,000 | 72,100 | 5,047 | 47 to 5 K (+10,638.30 %) |
Jun 07 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.47 | 60,000 | 2,308,440 | 3,012,964 | 3 M to 3 M (+2.03 %) |